London Stock Exchange-listed TyraTech Inc is a life sciences technology company focused on nature derived insect and parasite control products. After ten years of research, its flagship Vamousse head lice treatment and shampoo formulations has over the period 2015/2016 made significant market penetration. The expansion extended to cover more than thousands of stores in the US including Walmart, Walgreens and Rite Aid, the fourth largest pharmacy chain in the US.
In the UK sales have been made in almost 8,000 stores including Boots, Sainsbury’s Tesco’s and Morrison’s. Apart from Vamousse formulations the decade of research and development has resulted in 28 granted patents and 36 pending and the company says it is developing products for animal health markets.
Exchange: London AIM (TYR)
Financial Data from Exchange website: LSE Summary
Recent Financial Report: Final results for the year ending December 31 2016
TyraTech’s mission statement says: “The company is dedicated to making a lasting, positive impact on our ecosystem for the health and well-being of people and animals .There are more than 10 quintillion insects in the world (that’s 10 with 18 zeros) – and growing. And though many of those insects are beneficial to our ecosystem, others cause serious diseases and economic losses. To combat these risks, close to a billion tons of chemical pesticides are employed annually around the globe. And yet, we are losing the war against insects and parasites.
“All the while, insects and acarids are developing a resistance to many traditional synthetic pesticides, which leads to a risk of overuse, high toxicity, and environmental damage.
“We believe there is a better way. We believe there can be effective control of insects and the risks they pose without compromising safety. TyraTech develops insect and parasite products that do not rely on traditional pesticides. To achieve this, TyraTech puts nature to work. Its insect and parasite control products are created by enhancing the well-known natural insecticidal properties of plants to design formulas that are rooted in safety and efficacy.”
Contact Investor Relations
5151 McCrimmon Parkway Suite 275
Morrisville , NC 27560
Phone 001 919 415 4300
Chairman: Jose Barella
Short Description: Life Sciences Technologies